Skills this job asks for
Machine learningData engineeringTriagePython
Add your CV (free) to see which of these your CV is missing.
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 13 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 13 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.
Position
We seek a Senior Scientist with a demonstrated ability of successfully applying Cheminformatics and ML technologies to drive the discovery programs. You will collaborate closely with computational chemists, medicinal chemists, software engineers and machine learning experts to turn assay and structure-activity data into interpretable information for decision making. As an integral member of our Drug Discovery team, you will make a real and direct impact on accelerating the drug discovery process and ultimately benefiting patients.
About You
You’re a cheminformatics expert who loves to solve difficult problems and are not discouraged by challenges. You have a passion for drug discovery and thrive in a fast-paced, dynamic environment. You are curious, love challenges, and enjoy pushing the edge of technology to solve important problems with creative solutions. You’re collaborative by nature, resourceful, open-minded, data-driven, and can operate with a sense of urgency.
What You’ll Do
• Develop and apply cheminformatics data-mining algorithms for the analysis of molecular modeling, virtual screening, and structure-activity relationship (SAR) analysis.
• Process and analyze chemical and biological datasets to evaluate properties such as drug-likeness, ADMET properties, dosing, etc.
• Utilize molecular fingerprints, descriptors, and similarity metrics for compound clustering, classification, and regression.
• Assist in development, maintenance, and monitoring of AI/ML models used for property prediction.
• Optimize data pipelines for processing and storing chemical structures using cheminformatics toolkits (e.g., RDKit).
• Collaborate with cross-functional teams to integrate computational approaches into curation and analysis workflows.
• Maintain best practices in data integrity, reproducibility, and documentation of QSAR AI/ML models.
• Provide guidance on the application of modern cheminformatics, ML/AI methods for library design (e.g. diversity, focused, fragment, DEL) and analyzing large datasets from HTS campaigns to building predictive models from them.
• Routinely employ expert knowledge and analysis of SAR, physiochemical and ADMET properties.
• Work alongside medicinal chemists to further triage emerging hits from HTS.
• Collaborate closely with our data science team to integrate cutting edge AI/ML tools into our chemistry and drug discovery processes.
Qualifications
• Ph.D. plus 5 years of relevant experience; or Master's plus 14 years of relevant experience; or Bachelor's plus 16 years of relevant experience.
• Expertise in cheminformatics data analysis, data mining, and machine learning models to solve drug discovery problems.
• Expertise with ligand-based design approaches, QSAR, multiparameter optimization to rationalize SAR and design novel molecules.
• Expertise in scientific programming languages such as python, with experience using RDKit and other cheminformatic libraries and data analytics (Spotfire, DataWarrior, D360).
• Experience in virtual screening, HTS triaging, hit calling, and diversity analysis.
• Familiar with commercial platforms and ELN/registration systems (Schrödinger, OpenEye, MOE, Dotmatics, DataBricks, KNIME).
• A track record of publ
Apply on employer site ↗